CD8A and neoplasm: Although the specific antigens remain unidentified, these findings collectively suggest that APCs within the CBMC population may present tumor-derived antigens via MHC class I, enabling antigen-specific programming and expansion of CD8+ NKT-like cells during TPNC generation.